CD4 and neoplasm: As a consequence of d-MAPPS-induced increased antigen-presenting activity of tumor-infiltrated DCs (Figure 4), significantly higher number of antitumorigenic CD4+Th1 and Th17 cells were observed in the mammary cancers of 4T1+d-MAPPS-treated mice (Figures 5(a)–5(c)).